Hanson Pharmaceuticals: Report for the third quarter of 2024

SZSIOct 29 00:00 · Announcements

hunan hansen pharmaceutical (002412.SZ) released its performance for the first three quarters, with a net income of 0.131 billion yuan, a year-on-year increase of 19.15%.

hunan hansen pharmaceutical (002412.SZ) released the third quarter report for 2024, in the first three quarters, the company achieved revenue...

Zhitong FinanceOct 28 23:21

hunan hansen pharmaceutical (002412.SZ): net income of 0.131 billion yuan in the first three quarters, a year-on-year increase of 19.15%.

Gelonghui, on October 28th, Hunan Hansen Pharmaceutical (002412.SZ) released its third quarter report for 2024, achieving a revenue of 0.694 billion yuan in the first three quarters, a year-on-year increase of 1.44%; net income attributable to the shareholders of the listed company was 0.131 billion yuan, a year-on-year increase of 19.15%; net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 0.123 billion yuan, a year-on-year increase of 19.14%; and the basic earnings per share was 0.2598 yuan.

Gelonghui FinanceOct 28 21:48

Hunan Hansen Pharmaceutical Obtains Drug Registration for Diabetes Treatment Tablets

MT NewswiresOct 24 16:13

Express News | hunan hansen pharmaceutical: obtained the registration certificate of Engle net tablets pharmaceutical.

BreakingsOct 23 18:07

Hunan Hansen Pharmaceutical: Summary of Half-Year Report in 2024.

SZSIAug 14 00:00 · Announcements